Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart
Open accessThe DOI matches its Crossref record; 334 of the 340 references it cites were found in a registry or an index.
Abstract
Despite the significant decline in mortality, cardiovascular diseases are still the leading cause of death worldwide. Among them, myocardial infarction (MI) seems to be the most important. A further decline in the death rate may be achieved by the introduction of molecularly targeted drugs. It seems that the components of the PI3K/Akt signaling pathway are good candidates for this. The PI3K/Akt pathway plays a key role in the regulation of the growth and survival of cells, such as cardiomyocytes. In addition, it has been shown that the activation of the PI3K/Akt pathway results in the alleviation of the negative post-infarct changes in the myocardium and is impaired in the state of diabetes. In this article, the role of this pathway was described in each step of ischemia and subsequent left ventricular remodeling. In addition, we point out the most promising substances which need more investigation before introduction into clinical practice. Moreover, we present the impact of diabetes and widely used cardiac and antidiabetic drugs on the PI3K/Akt pathway and discuss the molecular mechanism of its effects on myocardial ischemia and left ventricular remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the cardiovascular system, GLP-1 can reduce cardiac ischemia-reperfusion injury through the activation of specific signaling pathways, such as the PI3K/Akt pathway.437,438”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [437]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Sun, L., Wang, H., Xu, D., Yu, S., Zhang, L., & Li, X. (2021) · Bioengineered · doi:10.1080/21655979.2021.2004980 · Cited by 136 · cited 1×
“[102] demonstrated in a cardiomyocyte (H9c2) cell culture that PI3K/Akt activation has a cardioprotective effect by reducing oxidative stress and inhibiting ferroptosis induced by doxorubicin (DOX) and lapatinib (LAP) [103,104].”
BackgroundRetractedSun, G., Lü, Y., Li, Y., Mao, J., Zhang, J., Jin, Y., Li, Y., Sun, Y., Liu, L., & Li, L. (2017) · Bioscience Reports · doi:10.1042/bsr20170899 · Cited by 36 · cited 1×
“miR-19 MiR-19a protects H9C2 cardiomyocytes against H/R-induced apoptosis by inhibiting PTEN [292]; MiR-19b promotes NRCFs proliferation and migration by targeting PTEN [293].”
BackgroundRetractedZhang, Z.-W., Li, H., Cui, Z., Zhou, Z., Chen, S., Ma, J., Hou, L., Pan, X., & Li, Q. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1652630 · Cited by 24 · cited 1×
“miR-122 up [295,301] Aggravates oxygen–glucose deprivation and reperfusion apoptosis of H9C2 cardiomyocytes inhibiting AKT/GSK-3β/β-catenin and AKT/mTOR pathway signaling [302,303];”
BackgroundRetractedGong, L., Chang, H. H., & Xu, H. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104325 · Cited by 9
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853 · cited 11×
“In turn, the overexpression of PTEN can be observed during MI, which inhibits the PI3K/Akt pathway and thus causes the opposite effect on IL-10, TNF-α, and MMP-2 expression, and in addition increases leukocyte infiltration in the myocardium and increases cardiomyocyte mortality.”
BackgroundInfluentialIbanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 2×
“observed that mTORC1 in vitro inhibits autophagosome formation by phosphorylation of unc-51-like autophagy activating kinase 1 (Ulk1) at Ser757 [186].”
Background
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“437,438 This involves modulating the cell apoptosis process, for example, by decreasing the Bax/Bcl-2 ratio in cardiomyocytes, reducing cytochrome C release, and caspase activation.”
BackgroundHypertensive heart disease: risk factors, complications and mechanisms
Masenga, S. K., & Kirabo, A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1205475 · Cited by 216
Regulation of bone homeostasis: signaling pathways and therapeutic targets
Wu, Z., Li, W., Jiang, K., Lin, Z., Qian, C., Wu, M., Xia, Y., Li, N., Zhang, H., Xiao, H.-X., et al. (2024) · MedComm · doi:10.1002/mco2.657 · Cited by 151
“158 Among them, the PH structural domain mediates the process of membrane translocation after AKT activation 159 ; the catalytic structural domain contains an ATP-binding site 160 ; and the C-terminal regulatory domain is proline-rich and contains another phosphorylation site, Ser473.”
BackgroundLiu, X., Li, D., Pi, W., Wang, B., Xu, S., Yu, L., Yao, L., Sun, Z., Jiang, J., & Mi, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109379 · Cited by 90
Song, M., Choi, D. B., Im, J. S., Song, Y. N., Kim, J. H., Lee, H., An, J., Kim, A., Choi, H. G., Kim, J., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06703-9 · Cited by 92
“…responses associated with IR injury and myocardial infarction [56] Thus, we presume that the increased population of endothelial cells in HOs may contribute to the more sensitive responses to hypoxia-induced apoptosis and the heightened production of in fl ammatory factors observed after IR injury.”
BackgroundCannavò, A., Jun, S., Rengo, G., Marzano, F., Agrimi, J., Liccardo, D., Elia, A., Keceli, G., Altobelli, G. G., Marcucci, L., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.321583 · Cited by 68
Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment
Xiong, P., Zhang, F., Liu, F., Zhao, J., Huang, X., Luo, D., & Guo, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114545 · Cited by 59
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure
Ouwerkerk, W., Pereira, J. P. B., Maasland, T., Emmens, J. E., Figarska, S. M., Tromp, J., Koekemoer, A. L., Nelson, C. P., Nath, M., Romaine, S. P. R., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.053 · Cited by 66
Natural compounds regulate the PI3K/Akt/GSK3β pathway in myocardial ischemia-reperfusion injury
Ajzashokouhi, A. H., Rezaee, R., Omidkhoda, N., & Karimi, G. (2023) · Cell Cycle · doi:10.1080/15384101.2022.2161959 · Cited by 56
“Upon binding PIP3, Akt undergoes a conformational change, facilitating its phosphoinositide-dependent kinase-1 (PDK1)-dependent phosphorylation [16].”
BackgroundFerroptosis in organ fibrosis: From mechanisms to therapeutic medicines
Lai, W., Wang, B., Huang, R., Zhang, C., Fu, P., & Ma, L. (2024) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2023-0137 · Cited by 56
“[109] Recently, more and more ferroptosis signaling pathways have been found to participate in cardiac fibrosis, including TRIM44/TLR4/NOX4 signaling, [110] SIRT1/ P53 signaling, [111] SIRT3/P53 signaling, [112] NCOA4 mediated ferritinophagy, [113] et al .”
BackgroundThe emerging roles of ferroptosis in organ fibrosis and its potential therapeutic effect
Huang, X., Song, Y., Wei, L., Guo, J., Xu, W., & Li, M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109812 · Cited by 45
Clavellina, D., Balkan, W., & Hare, J. M. (2023) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2023.2245329 · Cited by 42
“Akt-modified MSCs promoted cardio-myocyte survival while reducing apoptosis under hypoxic conditions [127].”
The Role of the PI3K/Akt/mTOR Axis in Head and Neck Squamous Cell Carcinoma
Jiang, Q., Xiao, J., Hsieh, Y.-C., Kumar, N. L., Han, L., Zou, Y., & Li, H. (2024) · Biomedicines · doi:10.3390/biomedicines12071610 · Cited by 222
Bai, B., Ji, Z., Wang, F., Qin, C., Zhou, H., Li, D., & Wu, Y. (2023) · Inflammation Research · doi:10.1007/s00011-023-01758-4 · Cited by 30
“The PI3K/Akt signal cascade has been shown convincingly to be associated with post-MI HF [32].”
BackgroundFang, Z., Yushanjiang, F., Wang, G., Zheng, X., & Jiang, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110876 · Cited by 31
Lin, X., Liu, W., Chu, Y., Zhang, H., Zeng, L., Lin, Y., Kang, K., Peng, F., Lin, J., Huang, C., et al. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14532 · Cited by 28
“7 Inhibition of cardiomyocyte apoptosis has been shown to delay the development of cardiac dilation and systolic dysfunction and improve heart failure.”
BackgroundIschemia–Reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction
Goncharov, R. G., & Sharapov, M. G. (2023) · Molecular Biology · doi:10.1134/s0026893323060067 · Cited by 25
Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives
Ovchinnikov, A. G., Potekhina, A. V., Arefieva, T. I., Filatova, A. Y., Ageev, F. T., & Belyavskiy, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094958 · Cited by 31
“While reducing ROCK and downstream molecule activation, statins may reduce immune cell migration to the myocardium and thereby suppress inflammation, which may ultimately benefit cardiac remodeling processes [79].”
BackgroundMairuae, N., Noisa, P., & Palachai, N. (2024) · Molecules · doi:10.3390/molecules29246046 · Cited by 22
Ejike, C. E. C. C., Ezeorba, T. P. C., Ajah, O., & Udenigwe, C. C. (2023) · Global Challenges · doi:10.1002/gch2.202200162 · Cited by 23
Transcriptomic Effects on the Mouse Heart Following 30 Days on the International Space Station
Veliz, A. L., Mamoun, L., Hughes, L., Vega, R., Holmes, B., Monteon, A., Bray, J. M., Pecaut, M. J., & Kearns‐Jonker, M. (2023) · Biomolecules · doi:10.3390/biom13020371 · Cited by 23
Ahmadabad, H. A., Panah, S. M., Ghasemnejad‐Berenji, H., Ghojavand, S., Ghasemnejad‐Berenji, M., & Khezri, M. R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03358-3 · Cited by 25
“Also, evidence shows during MI, the PI3K/AKT pathway activity can reduce the expression of pro-apoptotic factors and the release of cytochrome c and also increases the expression of BCL-2, which is an anti-apoptotic factor, which ultimately prevents apoptosis (Walkowski et al. 2022).”
InfluentialCucu, I., Nicolescu, M. I., Busnatu, Ș., & Manole, C. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105769 · Cited by 19
Zhao, M., Feng, L., & Li, W. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s480248 · Cited by 15
“67 The results of molecular interconnection showed that four components with high degree value were screened from notoginseng salvia miltiorrhiza according to the core genes (AKT1, TNF, TP53, IL6 and VEGFA), namely quercetin, luteotin, tanshinone iia and cryptotanshinone.”
MethodCircPAN3/miR-221/PTEN axis and apoptosis in myocardial Infarction: Quercetin's regulatory effects
Farazi, M. M., Rostamzadeh, F., Jafarinejad‐Farsangi, S., Moazzam‐Jazi, M., Jafari, E., & Gharbi, S. (2024) · Gene · doi:10.1016/j.gene.2024.148316 · Cited by 16
Alobaid, S. M., Alshahrani, R. M., Alonazi, A. S., Alrasheed, N. M., Alamin, M. A., Alshammari, T. K., Bin Dayel, A. F., Elnagar, D. M., Alotaibi, R. R., Almuthnabi, L. A., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17030374 · Cited by 13
“Extensive evidence supports the role of insulin in promoting cell survival through PI3K/AKT activation [10].”
BackgroundWang, W., Zhang, T., Yang, N., Wen, R., Wang, Y., Zhang, B., Yang, Y., & Liu, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122317 · Cited by 16
Mouse models of spontaneous atrial fibrillation
Keefe, J. A., Hulsurkar, M. M., Reilly, S. N., & Wehrens, X. H. T. (2022) · Mammalian Genome · doi:10.1007/s00335-022-09964-x · Cited by 15
The Pleiotropic Role of Extracellular ATP in Myocardial Remodelling
Sudi, S. B., Thomas, F. M., Daud, S. K., Daud, D. M. A., & Sunggip, C. (2023) · Molecules · doi:10.3390/molecules28052102 · Cited by 12
Ge, T., Ning, B., Wu, Y., Chen, X., Qi, H., Wang, H., & Zhao, M. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04876-z · Cited by 13
Dantas‐Komatsu, R. C. S., Cruz, M. S., Freire, P. P., Diniz, R. V. Z., Bortolin, R. H., Cabral-Marques, O., Souza, K. B. D. S., Hirata, M. H., Hirata, R. D. C., Reis, B. Z., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1151855 · Cited by 11
Singh, G., Varshney, V., Goyal, A., Ali, N., Iqbal, M., Kaur, I., Vargas-De-La-Cruz, C. B., & Behl, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22052 · Cited by 10
“However, this pathway gets downregulated in diabetic conditions [25,26].”
BackgroundWang, J., Hussain, S. A., Maddu, N., & Li, H. (2024) · Journal of physiological investigation. · doi:10.4103/ejpi.ejpi-d-24-00006 · Cited by 11
Nagy, R. N., Makkos, A., Baranyai, T., Giricz, Z., Szabó, M., Kravcsenko‐Kiss, B., Bereczki, Z., Ágg, B., Puskás, L. G., Faragó, N., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17313 · Cited by 11
“PI3K signalling plays a role in myocardial infarction and post-infarction cardiac remodelling, and several miRNAs were shown already to modulate its activation (Walkowski et al., 2022).”
Beetler, D. J., Giresi, P. G., Florio, D. N. D., Fliess, J. J., McCabe, E. J., Watkins, M. M., Xu, V., Auda, M. E., Bruno, K. A., Whelan, E. R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1468969 · Cited by 15
Cargo-Dependent Targeted Cellular Uptake Using Quaternized Starch as a Carrier
Blitsman, Y., Benafsha, C., Yarza, N., Zorea, J., Goldbart, R., Traitel, T., Elkabets, M., & Kost, J. (2023) · Nanomaterials · doi:10.3390/nano13131988 · Cited by 9
Exploring Cardiac Exosomal RNAs of Acute Myocardial Infarction
Jung, S. E., Kim, S. W., & Choi, J. (2024) · Biomedicines · doi:10.3390/biomedicines12020430 · Cited by 9
Parichatikanond, W., Duangrat, R., Nuamnaichati, N., & Mangmool, S. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.104952 · Cited by 8
Research progress on macrophages in cardiovascular diseases
Zhu, M., Zhou, H., Zhou, L., Yang, Y., & Chen, R. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03541-4 · Cited by 11
“Parajuli et al. demonstrated that phosphatase and ten-sin homolog (PTEN) negatively regulates the PI3K/Akt/ IL-10/TNF-α signaling pathway, leading to increased expression of anti-inflammatory M2 macrophage phenotype and playing an important role in remodeling after MI in mice [25].”
Lu, Y., Cui, J., Cheng, X., Li, J., Zhang, L., Tian, J., Yang, A., & Lin, Y. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10701-3 · Cited by 11
“…a reduced activity of the PI3K/AKT signaling pathway, promoting the abnormal activation of pro-inflammatory pathways such as NF-κB, which leads to the excessive release of inflammatory cytokines such as IL-6 and TNF-α, increasing myocardial inflammation and worsening myocardial injury [94, 96, 97].”
Ischemia-Reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction
Goncharov, R. G., & Sharapov, M. G. (2023) · Molecular Biology · doi:10.31857/s0026898423060071 · Cited by 18
Two Undescribed Coumarins from Notopterygium Incisum with Anti‐Inflammatory Activity
Hu, Y., Liu, M., Mu, Y., Li, C., Zhao, M., Guo, D., Huang, L., Gu, Y., Xue, Q., & Deng, Y. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401093 · Cited by 8
Patel, R., Kokori, E., Olatunji, G. D., Adejumo, F. A., Ukah, J. D., Babalola, A. E., Ndakotsu, A., Abraham, I. C., & Aderinto, N. (2025) · Current Heart Failure Reports · doi:10.1007/s11897-025-00704-1 · Cited by 10
Wang, W., Liu, H., Wen, Y., Zhang, Y., & Ma, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1619517 · Cited by 9
Arendt, N., Kopsida, M., Lennernäs, H., Sjöblom, M., & Heindryckx, F. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178282 · Cited by 11
“…and phosphorylation via Phos-phoinositide 3-kinase/AKT signaling has been demonstrated in murine models, where statins preserved endothelial and progenitor cell function against senescence and apoptosis (Kureishi et al., 2000; Walkowski et al., 2022; Weis et al., 2002; Zhao et al., 2021).”
Stem cell therapy as a promising approach for ischemic stroke treatment
Yaqubi, S., & Karimian, M. (2024) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2024.100183 · Cited by 13
“1) (Walkowski et al., 2022; Zhou et al., 2019).”
Hu, G., Chen, J., Chen, M., Yang, K., Wang, Y., Ma, Z., Bao, H., & Ding, X. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10533-7 · Cited by 8
“In the myocardium, Akt is a central signal transductor, and the PI3K/Akt pathway is responsible for proper metabolism and cell response [32].”
Li, J., Guo, Y., Yang, Y., Xue, Q., Cao, H., Yang, G., Sun, Z., Jia, L., & Yu, H. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04762-0 · Cited by 7
“In addition, activity of PI3K/ Akt signaling pathway has been proven to be related to ischemic pre-conditioning and ischemic post-conditioning [36].”
Xiao, Y., Zhao, Z., Chen, B., Sun, J., Wang, L., Wang, Y., Nan, Z., & Zhang, Q. (2025) · PeerJ · doi:10.7717/peerj.19221 · Cited by 8
“Emodin can downregulate FoxO1 expression through this pathway, thereby inhibiting liver glycogen output ( Ganesan & Xu, 2019 ; Qi et al., 2022 ; Walkowski et al., 2022 ).”
Žigová, L., Hrubá, O., KYSELOVIC, J., & Gažová, A. (2025) · Physiological Research · doi:10.33549/physiolres.935633 · Cited by 6
“Mechanisms regulating Cx43 through the Akt signaling pathway include phosphorylation, which impacts cell survival, modulates interactions with other proteins, and provides protective effects against apoptosis via Akt activation [44,45] (Fig .”
Jong, C.-B., Lu, T. E., Chen, T.-Y., Chen, C., Liao, M., Lin, I.-C., & Chen, J. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131195 · Cited by 6
Wan, F., Ma, X., Wang, J., An, Z., Xue, J., & Wang, Q. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03502-6 · Cited by 6
Tejera‐Muñoz, A., Guerra-Menéndez, L., Amor, S., González‐Hedström, D., García-Villalón, Á. L., & Granado, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914443 · Cited by 6
“The PI3K-Akt axis is reported to play a key role in maintaining adequate cardiac function and offering protection against various pathologies, including myocardial infarction [51].”
BackgroundMethodChaurembo, A. I., Xing, N., Chanda, F., Li, Y., Zhang, H., Fu, L.-D., Huang, J.-Y., Xu, Y.-J., Deng, W., Cui, H., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107164 · Cited by 9
Golforoush, P. A., Sulaiman, E., He, D., Yellon, D. M., & Davidson, S. M. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf111 · Cited by 6
“The PI3K/AKT pathway has been implicated in protection from numerous CVDs, including MI and heart failure, 41–43 highlighting its significance in maintaining cardiomyocyte viability and cardiac homoeostasis.”
Estepa, M., Niehues, M. H., Vakhrusheva, O., Haritonow, N., Ladilov, Y. V., Barcena, M. L., & Regitz‐Zagrosek, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179666 · Cited by 8
“…14 Therefore, we fi rst analyzed the phosphorylation, and thus the activation, of these kinases in myocardial tissue from male and It has been shown that ERK, p38, and AKT signaling pathways play a signi fi cant role in cardiac remodeling [22,23] and are a ff ected by CVB3-induced myocarditis [24,25].”
BackgroundEdo, G. I., Mafe, A. N., Akpoghelie, P. O., the Department of Veterans Affairs Cooperative Study Group o, Umelo, E. C., Yousif, E., Isoje, E. F., Igbuku, U. A., Opiti, R. A., Madueke, C. J., et al. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100754 · Cited by 5
Zhang, Z., Qin, S., Wang, Y., Liang, H., Wang, R., & Li, F. (2023) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-023-09962-x · Cited by 6
Unraveling the interplay between RAS axes and NOX signaling in fibroblasts during cardiac fibrosis
Chaturvedi, G., Chauhan, A., Dubey, N., Seth, S., Bhatia, J., Yadav, S. C., & Yadav, H. N. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05400-1 · Cited by 5
“It is protective in the acute phase where it inhibits apoptosis, inflammation and promotes angiogenesis and autophagy, thus limiting the chances of fibrotic changes [40].”
The role of mechanosignaling in the control of myocardial mass
Landim-Vieira, M., Morales, P. F. N., ElSafty, S., Kahmini, A. R., Ranek, M. J., & Solís, C. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00277.2024 · Cited by 5
Transcriptional, proteomic and metabolic drivers of cardiac regeneration
Cook, M., Lal, S., & Hume, R. D. (2025) · Heart · doi:10.1136/heartjnl-2024-325442 · Cited by 5
Beerwala, F. A., Kolambkar, S. V., Karikazi, A., Khatib, N. A., Bhandare, V. V., Roy, S., & Harish, D. R. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100010 · Cited by 6
Wang, J., Jing, K., Mitrokhin, V. M., Shileiko, S. A., Rodina, A., Zolotareva, A., Zolotarev, V. I., Bocharnikova, N., Kaminer, D. D., Antova, E., et al. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01099-2 · Cited by 5
Zhao, X., Gao, Z., Wen, W., & Zheng, S. (2023) · The Chinese Journal of Physiology · doi:10.4103/cjop.cjop-d-23-00103 · Cited by 5
Liu, Y., Yang, T., Hu, H., Yang, Q., Yang, J., & Chu, C. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110605 · Cited by 4
Yu, W., Chen, Z., Li, Y., Jiang, S., Zhang, L., Shao, X. M., & Xiao, D. (2024) · Reproductive Toxicology · doi:10.1016/j.reprotox.2024.108650 · Cited by 5
Karthikeyan, S. K., Nallasamy, P., Cleveland, J. M., Arulmani, A., Raveendran, A., Karimi, M., Ansari, M. O., Challa, A. K., Ponnusamy, M. P., Benjamin, I. J., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103525 · Cited by 3
“Downregulation of PI3K-Akt signaling indicates impaired adaptive mechanisms, including protein synthesis, cell cycle regulation, and apoptosis, though these processes remain partially intact [48,49].”
Antihypertensive potential of diosgenin: A comparative pharmacoinformatics study
Chahal, S., Debnath, A., Kumari, R., Ridhal, P., Sahoo, R. K., Biswal, B. K., Mishra, A., & Siwach, P. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110911 · Cited by 3
Li, X., Zhang, H., Li, W., Tuo, H., He, B., & Jiang, H. F. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04224-z · Cited by 3
“Its activation triggers the phosphorylation of Ser473 and Thr308 on the downstream Akt protein, thereby initiating the Akt signaling pathway [15].”
BackgroundKüçükler, S., Çomaklı, S., Özdemir, S., Değirmençay, Ş., Kandemır, F. M., Genç, A., Dalkılınç, E., & Aydın, Ş. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00315-1 · Cited by 2
“Therefore, maintaining balanced AKT activity is critical for cardiac function, as dysregulation may exacerbate cardiac dysfunction and disease progression [66].”
Zhang, Y., Gui, Y., Belke, D. D., Wang, X., Su, W., Liu, M., Yan, B., Sun, J., Hu, X., & Zheng, X. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02927-6 · Cited by 2
“These in vitro results show that MMF can directly protect cardiomyocytes from hypoxia-induced apoptosis, paralleling the in vivo fi ndings, and they set the stage for dissecting the signaling mechanisms involved.”
InfluentialHuang, S., Zhang, Y., Ma, T., Zhang, L., Lu, X., Fang, H., Lv, G., Chen, Z., Liu, X., Zhang, L., et al. (2026) · Analytical Cellular Pathology · doi:10.1155/ancp/8879160 · Cited by 2
“The PI3K/AKT pathway, a central regulator of energy metabolism, maintains dynamic equilibrium between glycolysis and oxidative phosphorylation through the phosphorylation of mTOR and FoxO by its downstream effector Akt [19, 28, 29].”
Nanomicelle‐Based Multi‐mRNA Delivery Promotes Cardiac Repair After Myocardial Infarction
Handa, K., Kawamura, T., Mano, Y., Nakanishi, H., Fujimura, L., Chie, K., Harada, A., Torigata, K., Miki, K., Itaka, K., et al. (2026) · Small Science · doi:10.1002/smsc.202500521 · Cited by 2
“The PI3K – Akt pathway is recognized as a key regulator of post-infarction repair, engaging downstream effectors including eNOS, VEGF, mTOR, and GSK-3 β to drive cell proliferation, angiogenesis, and cardiomyocyte survival [60 – 62].”
Atzemian, N., Dovrolis, N., Ragia, G., Portokallidou, K., Kolios, G. C., & Manolopoulos, V. G. (2023) · Biomedicines · doi:10.3390/biomedicines11102632 · Cited by 2
Rabaan, A. A., Alfaresi, M. S., AlRasheed, H. A., Kaabi, N. A., Abduljabbar, W. A., Fares, M. A. A., Al‐Subaie, M. F., & Alissa, M. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202400895 · Cited by 2
Xiao, L., Zhang, C.-R., Tang, Y., Li, Y., Zhu, Z., Qiu, T., & Zhao, J. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09933-7 · Cited by 3
“The PI 3 K/AKT pathway plays an important role in the pathogenesis of cardiac disease by regulating cardiomyocyte size and survival, angiogenic processes, and inflammatory responses [37].”
Tian, X., Chi, H., Liu, X., Zhang, Z., Li, Z., Yin, S., & Qiu, Q. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128375610250608071339 · Cited by 2
Yang, H. R., Zahan, M. N., Hwang, D. H., Prakash, R. L. M., Ravi, D. A., Hong, I., Kim, W. H., Kim, J.-H., Kim, E., & Kang, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041534 · Cited by 1
Zhang, H., Wang, H.-S., Kang, K., Chen, S., Chu, Y., Liu, W., Zhao, W., Zhou, Z., Shen, R., Lin, X., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178539 · Cited by 1
Beurton, A., Bordier, E., Veyret, S., Jaspard‐Vinassa, B., Hérion, F.-X., Oddos, C., Rienzo, M., Duranteau, J., Couffinhal, T., Imbault, J., et al. (2026) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2026.02.001 · Cited by 1
Jiang, Y., Xu, Z., Sun, X., Sun, S., Ding, K., Li, J., Chu, W., Chang, J., Sun, W., & Shi, L. (2026) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2026.105389 · Cited by 1
Floris, E., Cozzolino, C., Buonaiuto, G., Taliani, V., Bordin, A., Palma, A., Picchio, V., Dhori, X., Nutile, F., Nicoletti, C., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08636-x · Cited by 1
“These are known to have an important role in cardiac adaptation [28], as well as in response to mechanical and oxidative stress, and to ischemia/ reperfusion injury [29, 30].”
Gardev, A., Hausenloy, D. J., & Pekcec, A. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag100 · Cited by 2
“…of the 46 proteins included in our analysis converged on a limited set of Protein therapies for ischaemic-reperfusion injury well-established signalling pathways involved in cardiac repair and remodelling after MI. 65–67 Sixteen of the proteins studied targeted more than one pathway ( Figure 2 ).”
Exercise-specific epigenetic effects on cardiovascular health
Huang, Y., Yang, Z., Chu, Z., Zhang, Z., Huang, X., Zheng, C., Chen, Y., & Pu, J. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02169-y · Cited by 1
Liang, J., Qiu, X., Xu, L., Shao, S., Liu, L., Yang, N., Qin, X., Rejiepu, M., Tang, B., & Zhang, L. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120570 · Cited by 1
Wu, M., Qi, H., Li, J., Velu, P., & Han, X. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073285839240808113152 · Cited by 1
Advances in the Design of Novel Antidiabetic Agents Using In-silico Approaches
Jadhav, S., Yeram, P. B., Alavala, R. R., & Vora, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-4154-3_21 · Cited by 2
Liu, T., Zhang, Q., Zhao, F., Yin, J., Liu, H., Wang, L., & Liu, B. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00197-3 · Cited by 1
“PI3K/Akt plays a critical role in modulating the growth and survival of cells including cardiomyocytes [22].”
Transcriptomic Insights into Early Diagnosis of Doxorubicin-Induced Cardiotoxicity in a Rat ModelPreprint
Anca, E., Pavel, I.-O., Licărete, E., Roşioru, C., Dobre, C., & Banciu, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.01.646673 · Cited by 1
“The PI3K-Akt pathway is a key intracellular signal transduction pathway, with critical role in maintaining heart tissue homeostasis by controlling many processes such as cardiomyocyte growth, survival and stress responses [26].”
Schröder, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00012-x
French Paradox: A Role for Akt Activation
Gallyas, F., Bock-Marquette, I., Tóth, K., & Halmosi, R. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-62806-1_20
Zare, A., Khosropanah, S., Daryabor, G., & Doroudchi, M. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01703-4
“This pathway has been studied in a variety of human diseases such as cancer [7, 8], diabetes [9], atherosclerosis [10], cardiovascular disease [11] and obesity [12].”
BackgroundThe importance of biomarkers of post-myocardial infarction heart failure: a systematic review
Vásquez-Donet, C. A., Bazualdo-Fiorini, E. R., Alvarado, T. W. S., Portilla-Linares, M. M., Valdez-Portilla, J., & Barrera-Benavides, L. G. (2023) · Health Leadership and Quality of Life · doi:10.56294/hl2023262
Emerging Insights into Sall4’s Role in Cardiac Regenerative Medicine
Yang, J. (2025) · Cells · doi:10.3390/cells14030154
Genomic Studies in Cardiovascular Research
Ding, H., Zhang, Y., & Liu, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00042-x
Gao, N., Wu, P.-F., Wu, M., Li, Y., Xu, L., Wang, F.-F., Li, X.-J., Shen, Q.-Q., Zheng, T.-P., Liu, X., et al. (2025) · World Journal of Experimental Medicine · doi:10.5493/wjem.v15.i3.103948
Li, S., Zhang, Z., Gong, M., Li, X., Jia, X., Chen, Y., Tang, X., & Wang, W. (2025) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2025.12.002
Beerwala, F. A., Kolambkar, S. V., Karikazi, A., Virge, R., Desai, A., Gupta, S., Darasaguppe, H. R., Khatib, N. A., & Roy, S. (2025) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-025-00666-3
Song, Z.-Q., Wang, B.-X., Zhou, Z.-B., Wu, S.-K., Sun, Y., & Chen, Y.-H. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02048-6 · Cited by 2
“…was positively associated with non-ischemic HFpEF, aligning with the central, generally cardioprotective role of PI3K/AKT signaling in myocardial survival, relaxation, and anti-fibrotic responses; inhibition of this pathway is linked to adverse remodeling and diastolic dysfunction [50, 51].”
Liu, J., Lyu, Q., Li, J., He, X., & Leng, J. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134450
Metadata
- Authors
- Walkowski, B., Kleibert, M., Majka, M., & Wojciechowska, M.
- Affiliations
- Medical University of Warsaw (PL)
- Corresponding author
- Kleibert, Marcin
- Majka, Miłosz
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-05-05
- Volume
- 11
- Issue
- 9
- Pages
- 1553
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC9105930
- OpenAlex
- W4280571486
- Cited by
- 117
- References
- 340
- Citations by year
- 2026: 27 · 2025: 31 · 2024: 28 · 2023: 28 · 2022: 3
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Publishing Fund of the Medical University of Warsaw (1MA/N/2022)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- PI3K/Akt signaling, myocardial ischemia, myocardial infarction, diabetic cardiomyopathy, diabetic heart, cardiomyocyte survival, molecularly targeted agents, antidiabetic drugs, cardiovascular drugs
- MeSH terms
- Diabetes Mellitus, Humans, Myocardial Infarction, Apoptosis, Phosphatidylinositol 3-Kinases, Ventricular Remodeling, Myocytes, Cardiac, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.